Marathon Capital Management’s Calix CALX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.12M Buy
83,555
+1,800
+2% +$75.5K 0.63% 44
2026
Q1
$4.01M Buy
81,755
+1,170
+1% +$61.4K 0.9% 38
2025
Q4
$4.27M Buy
80,585
+385
+0.5% +$22.4K 0.92% 37
2025
Q3
$4.92M Sell
80,200
-16,435
-17% -$946K 1.13% 29
2025
Q2
$5.14M Sell
96,635
-17,755
-16% -$759K 1.31% 23
2025
Q1
$4.05M Sell
114,390
-745
-0.6% -$27.6K 1.08% 28
2024
Q4
$4.01M Sell
115,135
-5,705
-5% -$201K 1% 29
2024
Q3
$4.69M Buy
120,840
+30,425
+34% +$1.12M 1.14% 23
2024
Q2
$3.2M Buy
90,415
+6,775
+8% +$218K 0.82% 33
2024
Q1
$2.77M Buy
83,640
+26,535
+46% +$989K 0.66% 39
2023
Q4
$2.49M Buy
57,105
+3,025
+6% +$121K 0.63% 43
2023
Q3
$2.48M Buy
+54,080
New +$2.45M 0.62% 45

Other funds holding CALX

Marathon Capital Management's CALX Position: Q2 2026 in Review

Marathon Capital Management increased its Calix (CALX) stake by 2.2% in Q2 2026, buying an estimated $75.5K and bringing the position to 83,555 shares worth $3.12M. The position accounts for 0.63% of the portfolio, ranked #44.

Marathon Capital Management first reported a position in CALX in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.14M in Q2 2025. 287 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • Marathon Capital Management held 83,555 shares of Calix worth $3.12M as of Q2 2026.
  • Marathon Capital Management bought 1,800 Calix shares in Q2 2026, an estimated $75.5K.
  • Calix made up 0.63% of Marathon Capital Management's portfolio in Q2 2026, its #44 holding.
  • Marathon Capital Management first reported a position in Calix in Q3 2023 and has held it in 12 quarters since.
  • Marathon Capital Management's Calix position peaked at $5.14M in Q2 2025.
  • 287 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on Marathon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.